For instance, PCSK9 mutations affect LDL-C levels, and loss-of-function mutations are associated with a lower risk of stroke, indicating that PCSK9 inhibitors may be used therapeutically to prevent strokes [29]. Here, PCSK9 is linked to stroke disorder.